Home

T Cell Companies and Organizations

Companies working with T-Cells also work in 36 other areas:

The number of employers follows the core activity.

75 Employers in 101 Locations

A2 Biotherapeutics

Description: 

A biotech startup working on engineered T-cell therapies to treat ...

Abata Therapeutics

Description: 

Abata Therapeutics is using regulatory T cells develop treatments for ...

Achilles Therapeutics

Description: 

Achilles Therapeutics is a biopharmaceutical company developing personalized T cell ...

Adaptate Biotherapeutics

Description: 

Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma ...

Adaptimmune

Description: 

Revolutionizing cancer therapy on a global basis by developing TCR ...

Adaptive Biotechnologies

Description: 

T Cell and B Cell receptor analysis with Clonoseq. ...

Adicet Bio

Description: 

Working on off-the-shelf cellular therapies that may offer the anticancer ...

Affini-T Therapeutics

Description: 

Affini-T is pioneering engineered TCR T cell therapies with cutting-edge ...

Alaunos

Description: 

Alaunos is a clinical stage cellular immuno-oncology company dedicated to ...

Artielle ImmunoTherapeutics

Description: 

Recombinant T Cell Receptor Ligands

Atara Biotherapeutics

Description: 

Atara Bio’s programs include T-cell product candidates and molecularly-targeted product ...

Autolus

Description: 

Autolus is at the forefront of a revolution in cancer ...

AVM Biotechnology

Description: 

Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative ...

Bellicum Pharmaceuticals

Description: 

Develops next-generation product candidates in some of the most important ...

BioCopy

Description: 

BioCopy uses microarray technology for immune profiling and lead screening ...

Biotecnol

Business Area(s): 
  • Antibodies
  • Immunology
  • T-Cells
    • Description: 

    Antibody technology

    Bluebird Bio

    Description: 

    The cancer immunotherapy research group is focused on the next ...

    CDR-Life

    Business Area(s): 
  • Immunotherapy
  • T-Cells
  • Cancer
    • Description: 

    CDR-Life is a biotherapeutics company developing targeted cancer immunotherapies. Their ...

    Cellectis

    Description: 

    The company develops immunotherapies for blood and bone marrow cancers ...

    Chimera Bioengineering

    Description: 

    Chimera Bioengineering solves the challenges of CAR-Ts with RNA-based gene ...

    Connect Biopharma

    Description: 

    Connect Biopharma is building a rich pipeline of internally designed, ...

    Coya Therapeutics

    Description: 

    Coya Therapeutics, a clinical stage cell therapy platform company developing ...

    CytomX Therapeutics

    Description: 

    Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics ...

    Cytovia Therapeutics

    Description: 

    Cytovia aims to accelerate patient access to transformational cell ...

    Egle Therapeutics

    Business Area(s): 
  • T-Cells
  • Immunology
    • Description: 

    Egle Therapeutics has been founded with a vision to become ...

    Eureka Therapeutics

    Description: 

    Focusing on developing safe and effective T-cell therapies with the ...

    Flexomics

    Business Area(s): 
  • Single Cell Analysis
  • T-Cells
    • Description: 

    Single-cell analysis company focused on the high-throughput identification and ...

    GammaDelta Therapeutics

    Description: 

    Exploring therapeutic uses of gamma / delta (γ/δ) TCR producing ...

    GentiBio

    Description: 

    GentiBio works on regulatory T-Cell (Tregs) cell therapies to restore ...

    GigaMune

    Description: 

    GigaMune was founded as a spin-out from GigaGen in 2017 ...

    Grupo Maxwerk / Maxwerk Biotech

    Description: 

    Maxwerk Biotech Division has a pipeline that consists of Genetically ...

    Harpoon Therapeutics

    Business Area(s): 
  • Immuno-oncology
  • T-Cells
    • Description: 

    Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel ...

    Immunocore

    Business Area(s): 
  • T-Cells
  • Antibodies
    • Description: 

    Develops ImmTAC® (Immune mobilising monoclonal TCRs against cancer). These molecules ...

    Immutep

    Business Area(s): 
  • Immunotherapy
  • Cancer
  • T-Cells
    • Description: 

    Developing therapeutics that modulate Lymphocyte Activation Gene-3 or "LAG-3” which ...

    IMV

    Description: 

    IMV is a clinical-stage biopharmaceutical company leveraging our proprietary drug ...

    IN8bio

    Business Area(s): 
  • Cell and Gene Therapy
  • T-Cells
    • Description: 

    IN8bio was founded with the mission of developing next-generation ...

    Indapta Therapeutics

    Business Area(s): 
  • T-Cells
  • Cancer
    • Description: 

    Indapta Therapeutics is a biotechnology company focused on developing and ...

    Indee Labs

    Description: 

    Their mission is to enable T cell immunotherapy manufacturing through ...

    Instil Bio

    Business Area(s): 
  • T-Cells
  • Cancer Therapeutics
    • Description: 

    Instil Bio, Inc is a global, clinical-stage cell therapy company ...

    iTeos Therapeutics

    Business Area(s): 
  • T-Cells
  • Cancer
  • Immunotherapy
    • Description: 

    iTeos Therapeutics is targeting the tumor microenvironment to enhance the ...

    Kyverna Therapeutics

    Description: 

    Kyverna Therapeutics is navigating what’s next in synthetic biology, immunology ...

    Lava Therapeutics

    Description: 

    Lava Therapeutics B.V. is a biotechnology company, founded in 2016, ...

    Lion Biotechnologies

    Description: 

    Develops tumor-infiltrating T cells designed to overcome the immunosuppressive effects ...

    Lyell Immunopharma

    Description: 

    Lyell's goal is to develop curative cell-based immunotherapies for any ...

    Marengo Therapeutics

    Description: 

    Marengo’s approach mimics natural mechanisms of non-clonal T cell receptor ...

    Marker Therapeutics

    Description: 

    Marker Therapeutics is a clinical-stage immuno-oncology company specializing in the ...

    Maverick Therapeutics

    Description: 

    Develop bispecific antibodies that activate T cells and initiate tumor ...

    Medigene

    Description: 

    Medigene concentrates on the development of personalized T cell-based immunotherapies.

    MiNK Therapeutics

    Description: 

    MiNK Therapeutics is a clinical-stage precision oncology company developing allogeneic, ...

    Mustang Bio

    Description: 

    Mustang Bio, Inc., a subsidiary of Fortress Biotech, Inc., is ...

    Nanjing Legend Pharmaceutical & Chemical

    Business Area(s): 
  • Small Molecules
  • T-Cells
    • Description: 

    Nanjing Legend Pharmaceutical & Chemical Co., Ltd is a research-based ...

    NantKwest

    Description: 

    Develops immunotherapeutics that activate natural killer cells.

    COVID-19: Received ...

    Neogene Therapeutics

    Description: 

    Neogene creates tailored T cell therapies designed for each individual ...

    NeoTX Therapeutics

    Description: 

    NeoTX uses its Selective T cell Redirection (STR) platform to ...

    NKT Therapeutics

    Business Area(s): 
  • T-Cells
    • Description: 

    Natural Killer T-Cell Therapeutics

    ONK Therapeutics

    Business Area(s): 
  • T-Cells
  • Cell and Gene Therapy
    • Description: 

    ONK Therapeutics is dedicated to optimizing a next generation of ...

    Osivax

    Description: 

    Clinical-stage biotech company developing vaccines and ​immunotherapies eliciting powerful CD8+ ...

    Oxford Vacmedix

    Business Area(s): 
  • Cancer
  • Immunotherapy
  • T-Cells
    • Description: 

    Develops peptides to stimulate cytotoxic T-Cells.

    PACT Pharma

    Description: 

    Developing personalized adoptive cell therapies with neoantigen-targeted T Cells against ...

    Poseida Therapeutics

    Description: 

    Poseida Therapeutics is a spin out of Transposagen Biopharmaceuticals that ...

    Quell Therapeutics

    Business Area(s): 
  • T-Cells
  • Cell and Gene Therapy
    • Description: 

    Quell seeks to be a global biopharmaceutical company bringing therapies ...

    Repertoire Immune Medicines

    Description: 

    Repertoire Immune Medicines is a Flagship Pioneering company working to ...

    Root Path

    Description: 

    RootPath is a Cambridge-based biotechnology company developing a personalized T ...

    Shoreline Biosciences

    Description: 

    Shoreline Biosciences is developing allogeneic, off-the-shelf, targeted, and standardized immunotherapies ...

    Shorla Oncology

    Description: 

    Shorla Oncology is developing and commercializing oncology drugs

    Sonoma Biotherapeutics

    Description: 

    Sonoma Biotherapeutics, is a privately held company developing regulatory T ...

    Sorrento Therapeutics

    Description: 

    Developing novel immunotherapies against medically-relevant targets utilizing Sorrento’s unique portfolio ...

    T-knife

    Business Area(s): 
  • T-Cells
    • Description: 

    T-knife develops a proprietary transgenic HuTCR mouse platform to produce ...

    Tmunity Therapeutics

    Description: 

    Tmunity is developing a diversified portfolio of novel treatments that ...

    TScan Therapeutics

    Description: 

    TScan is developong T cell therapies.

    Virax Biolabs

    Business Area(s): 
  • Diagnostics
  • T-Cells
    • Description: 

    Developing an immunology platform based around T-Cell testing.

    Vor BioPharma

    Description: 

    Vor BioPharma is working to develop engineered hematopoietic stem cells ...

    Wugen

    Description: 

    Wugen is developing off-the-shelf cellular therapies for cancer. Their NK ...

    Xenetic Biosciences

    Description: 
    Xenetic Biosciences is a biopharmaceutical company focused on advancing XCART™, ...

    Xyphos

    Description: 

    Xyphos is an Astellas company. Their CAR-T technology exploits a ...

    Don't see an employer? Please fill out the form